REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 38,537 ordinary shares between June 9 and June 12 under its previously announced share repurchase program. The company paid a total of €954,808.90 for the shares, reflecting an average purchase price of €24.7764 per share.
Key figures
- Lowest price paid
- 24.36
- Average price paid
- 24.7764
- Highest price paid
- 25.08
- Shares repurchased
- 38537
- Total repurchase cost
- €954,808.90
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.